No products in the cart.

Anti-NFkB p100 antibody

SKU Product Brand Unit Availability Price Quantity  
AB-06-3124
Anti-NFkB p100 antibody
Erpan Tech In stock

Specifications        

Product Cat#: AB-06-3124
Product type: Primary antibody
Antigen: NFkB p100
Immunogen: Recombinant protein
Species immunized: Rabbit
Isotype: IgG
Applications:  Western Blot (1:200-1:2000);Immunocytochemistry (1:100-1:200)/Immunofluorescence; Immunoprecipitation; Immunohistochemistry (1:100-1:200)
Reactivity: Mouse, Rat and Human
Clonality (clone number): Monoclonal(JM82-03)
Form: Liquid
Buffer: 1*TBS (pH7.4), 1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration: 1 mg/ml
Purity: Protein A affinity purified
Storage: Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles.
Alternative names: CVID10 antibody
DNA binding factor KBF2 antibody
H2TF1 antibody
Lymphocyte translocation chromosome 10 protein antibody
LYT 10 antibody
NF kB2 antibody
NFKB p52/p100 subunit antibody
Nuclear factor Kappa B subunit 2 antibody
Nuclear factor of kappa light polypeptide gene enhancer in B cells 2 (p49/p100) antibody
Nuclear factor of kappa light polypeptide gene enhancer in B cells 2 antibody
Oncogene Lyt 10 antibody

 

Show More

Target information

NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. In a non-canonical activation pathway, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. The NF-kappa-B heterodimeric RelB-p52 complex is a transcriptional activator. The NF-kappa-B p52-p52 homodimer is a transcriptional repressor. NFKB2 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p100 and generation of p52 by a cotranslational processing. The proteasome-mediated process ensures the production of both p52 and p100 and preserves their independent function. p52 binds to the kappa-B consensus sequence 5′-GGRNNYYCC-3′, located in the enhancer region of genes involved in immune response and acute phase reactions. p52 and p100 are respectively the minor and major form; the processing of p100 being relatively poor. Isoform p49 is a subunit of the NF-kappa-B protein complex, which stimulates the HIV enhancer in synergy with p65. In concert with RELB, regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer.

Provider

Erpantech Laboratory

download

MSDS-AB-06-3124.pdf (170 downloads )